Ubs Global Asset Management Americas »

Alnylam Pharmaceuticals shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2023-12-31 $142M 741k 191.41
2023-09-30 $137M 775k 177.10
2023-06-30 $135M 674k 200.32
2023-03-31 $135M 674k 200.32
2022-12-31 $156M 658k 237.65
2022-09-30 $121M 604k 200.16
2022-06-30 $87M 593k 145.85
2022-03-31 $99M 605k 163.29
2021-12-31 $109M 641k 169.58
2021-09-30 $122M 646k 188.81
2021-06-30 $106M 623k 169.52
2021-03-31 $94M 666k 141.19
2020-12-31 $105M 723k 145.60
2020-09-30 $105M 723k 145.60
2020-06-30 $124M 838k 148.11
2020-03-31 $91M 831k 108.85
2019-12-31 $95M 824k 115.17
2019-09-30 $64M 791k 80.42
2019-06-30 $70M 965k 72.56
2019-03-31 $108M 1.2M 93.45
2018-12-31 $103M 1.4M 72.91
2018-09-30 $116M 1.3M 87.52
2018-06-30 $134M 1.4M 98.49
2018-03-31 $160M 1.3M 119.10
2017-12-31 $177M 1.4M 127.05
2017-09-30 $160M 1.4M 117.49
2017-06-30 $116M 1.4M 79.76
2017-03-31 $89M 1.7M 51.25
2016-12-31 $63M 1.7M 37.49
2016-09-30 $103M 1.5M 67.78
2016-06-30 $92M 1.7M 55.47
2016-03-31 $104M 1.7M 62.76
2015-12-31 $181M 1.9M 94.12
2015-09-30 $154M 1.9M 80.36
2015-06-30 $218M 1.8M 119.86
2015-03-31 $185M 1.8M 104.46
2014-12-31 $155M 1.6M 97.01
2014-09-30 $135M 1.7M 78.09
2014-06-30 $108M 1.7M 63.19
2014-03-31 $112M 1.7M 67.17
2013-12-31 $102M 1.6M 64.29
2013-09-30 $79M 1.2M 64.01
2013-06-30 $42M 1.3M 31.01